From the Editor - BioPharm International

ADVERTISEMENT

From the Editor

Defining Quality Metrics is No Easy Task

February 1, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

Drugs At What Cost?

January 1, 2014

Generics, market dynamics, and global demand are changing drug spending patterns.

Jobs Are Better in Biopharma, But There Is Room for Improvement

December 1, 2013

Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.

New Funding and Approval Pathways Prove Popular

November 1, 2013

The JOBS Act and FDASIA show early signs of accelerating drug development.

Filling a Drug Safety Gap

August 1, 2013

As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.

The Pains of Change

July 1, 2013

Pharma and biotech companies, with the rest of the healthcare industry, must face change.

Trust in the Pill Bottle

June 1, 2013

Ranbaxy's $500 million settlement for producing adulterated drugs and fradulent data provides a cautionary tale for patients, FDA, and drug manufacturers.

The Pathway to Publication

May 1, 2013

Wanted: Aspiring authors to share technical and scientific solutions for biopharmaceutical processing.

Catching Up

March 1, 2013

A QbD paradigm advances process understanding in development and manufacturing.

ADVERTISEMENT

ADVERTISEMENT

Click here